Jerry Wan
Vermögen: 209 895 $ am 31.07.2026
Vermögen: 209 895 $ am 31.07.2026
Jerry Wan is currently Vice President-Finance at Achieve Life Sciences, Inc. since 2025, with employment at the firm starting in 2017.
Formerly, Mr. Wan was Director-Accounting Operations at OncoGenex Pharmaceuticals, Inc. from 2014 to 2017 and Manager-Management Reporting at Gateway Casinos & Entertainment Ltd. from 2010 to 2011.
Education includes an undergraduate degree from the University of British Columbia.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 28.01.2026 | 32’694 ( 0.03% ) | 209 895 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. | Corporate Officer/Principal | 01.02.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies that address treatment resistance in cancer patients | Finanzdirektor/CFO | 01.07.2014 |
Gateway Casinos & Entertainment Ltd.
Gateway Casinos & Entertainment Ltd. Hotels/Resorts/Cruise linesConsumer Services Operates and manages casinos & hotels | Corporate Officer/Principal | 01.01.2011 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Gateway Casinos & Entertainment Ltd.
Gateway Casinos & Entertainment Ltd. Hotels/Resorts/Cruise linesConsumer Services Operates and manages casinos & hotels | Consumer Services |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies that address treatment resistance in cancer patients | Health Technology |
Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen